News

Dexcom has revealed its next-generation continuous glucose monitor, the Dexcom G8, featuring a smaller design, extended 15-day wear time, and innovative adaptive accuracy technology. The company also revealed plans for future ketone and potassium monitoring, offering an early look at how diabetes technology may become more personalised, intelligent, and comprehensive in the years ahead.

From 1 July 2026, eligible NDSS users currently accessing FreeStyle Libre 2 sensors will be automatically upgraded to FreeStyle Libre 2 Plus. In this article you will find what the change means, the key differences between the two systems, how the NDSS subsidy works, who is eligible, and answers frequently asked questions about the transition.

Australia has approved Tzield, the first new therapy for type 1 diabetes in over 100 years. The treatment can delay progression to stage 3 T1D and the need for insulin therapy in people aged 8+ with stage 2 type 1 diabetes.

Glucology is proud to partner with The Type 1 Foundation to support newly diagnosed Type 1 families in Australia. Selected Glucology products are now helping support patients at diagnosis, and the range is also available in The Type 1 Foundation store in Geelong.

We're thrilled to announce that Glucology is now a core range partner with UFS Healthcare Group across all 19 of their pharmacies and clinics!

Glucology CGM Overpatches are now available in all Chemist Warehouse stores across New Zealand. Learn more about this milestone and how it supports easier access to practical diabetes care products.